Drugs for Neglected Diseases initiative (DNDi) / dndi_transparency-activities
Paediatric HIV and cryptococcal meningitis
CH-FDJP-CHE110141200-18
EUR 22.04mdeclared budget
EUR 18.50mdisbursed and spent, 1,569 of 1,569 transactions
Implementationstatus
31 Dec 2028planned end
Budget over time
- Reporting organisation
- Drugs for Neglected Diseases initiative (DNDi)
- Start
- 01 Jan 2016 (planned)
- Countries
- —
- Sectors
- Health policy and administrative management (12110) 10%; Medical services (12191) 10%; Basic health infrastructure (12230) 10%; Infectious disease control (12250) 50%; Health education (12261) 5%; Health personnel development (12281) 15%; 121 · OECD DAC 3-digit 20%; 122 · OECD DAC 3-digit 80%; 3 · SDG goal 100%; 3.3 · SDG target 100%; 3.3.5 Number of people requiring interventions against neglected tropical diseases · SDG indicator 100%
- Funded by
- Drugs for Neglected Diseases initiative
- Participating
- Drugs for Neglected Diseases initiative (funding)
- Versions seen
- 2 since 26 Sept 2026 · last checked 2026-10-03 02:26 UTC
Changes
- 2026-10-03Budget changed+1 more
Budget EUR 20.51m → EUR 22.04m (+7.5%)
- Transactions added: 297 transactions added, EUR 2.14m
Paediatric HIV and cryptococcal meningitis · compare 0fbd0f94 → 795bcf10
Budgets
| Period | Type | Value | Record |
|---|---|---|---|
| 2019-01-01 → 2019-12-31 | revised, indicative | EUR 3.32m | new since 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | revised, indicative | EUR 3.80m | new since 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | revised, indicative | EUR 3.51m | new since 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | revised, indicative | EUR 2.15m | new since 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | revised, indicative | EUR 2.42m | new since 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | revised, indicative | EUR 2.67m | new since 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | revised, indicative | EUR 2.63m | new since 02 Oct 2026 |
| 2025-01-01 → 2025-12-31 | revised, indicative | EUR 1.53m | new since 02 Oct 2026 |
| 2019-01-01 → 2019-12-31 | original | EUR 3.32m | superseded, last seen 02 Oct 2026 |
| 2020-01-01 → 2020-12-31 | original | EUR 3.80m | superseded, last seen 02 Oct 2026 |
| 2018-01-01 → 2018-12-31 | original | EUR 3.51m | superseded, last seen 02 Oct 2026 |
| 2021-01-01 → 2021-12-31 | original | EUR 2.15m | superseded, last seen 02 Oct 2026 |
| 2022-01-01 → 2022-12-31 | original | EUR 2.42m | superseded, last seen 02 Oct 2026 |
| 2023-01-01 → 2023-12-31 | original | EUR 2.67m | superseded, last seen 02 Oct 2026 |
| 2024-01-01 → 2024-12-31 | original | EUR 2.63m | superseded, last seen 02 Oct 2026 |
Transactions
| Date | Type | Value | To | Note | Record |
|---|---|---|---|---|---|
| 2021-01-31 | Expenditure | EUR 1,274 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-BR | |
| 2021-01-31 | Expenditure | EUR -1,478 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-CD-CH-4 | |
| 2021-01-31 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-CH-FR-3 | |
| 2021-01-31 | Expenditure | EUR 8,021 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-2-CH | |
| 2021-01-31 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 18-2101-3-CH | |
| 2021-01-31 | Expenditure | EUR 28k | Drugs for Neglected Diseases initiative | Expenses - 18-2101-4-CH | |
| 2021-01-31 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 18-2101-5-CH-CH-4 | |
| 2021-01-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-ES-CH-4 | |
| 2021-01-31 | Expenditure | EUR -3,809 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-FR | |
| 2021-01-31 | Expenditure | EUR 3,752 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-GB | |
| 2021-01-31 | Expenditure | EUR 7,087 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-2-GB-CH-4 | |
| 2021-01-31 | Expenditure | EUR 1,667 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-IN | |
| 2021-01-31 | Expenditure | EUR 46 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-2-IN-CH-4 | |
| 2021-01-31 | Expenditure | EUR 9,460 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-KE-FR-3 | |
| 2021-01-31 | Expenditure | EUR 697 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-2-KE | |
| 2021-01-31 | Expenditure | EUR 6,184 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-3-KE | |
| 2021-01-31 | Expenditure | EUR 3,693 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-4-KE-CH-4 | |
| 2021-01-31 | Expenditure | EUR 162 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-MY | |
| 2021-01-31 | Expenditure | EUR 257 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-2-MY | |
| 2021-01-31 | Expenditure | EUR 1 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-3-MY-CH-4 | |
| 2021-01-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-TH-CH-4 | |
| 2021-01-31 | Expenditure | EUR 19 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-US | |
| 2021-01-31 | Expenditure | EUR 8,372 | Drugs for Neglected Diseases initiative | Expenses - 18-2101-2-US-CH-4 | |
| 2021-01-31 | Expenditure | EUR -79k | Drugs for Neglected Diseases initiative | Expenses - 18-2101-1-ZA | |
| 2021-02-28 | Expenditure | EUR 21k | Drugs for Neglected Diseases initiative | Expenses - 18-2102-1-CH-FR-3 | |
| 2021-02-28 | Expenditure | EUR 7,217 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-2-CH | |
| 2021-02-28 | Expenditure | EUR 16k | Drugs for Neglected Diseases initiative | Expenses - 18-2102-3-CH | |
| 2021-02-28 | Expenditure | EUR 9,723 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-4-CH | |
| 2021-02-28 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 18-2102-5-CH-CH-4 | |
| 2021-02-28 | Expenditure | EUR 6,555 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-1-GB-CH-4 | |
| 2021-02-28 | Expenditure | EUR 6,360 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-1-KE-FR-3 | |
| 2021-02-28 | Expenditure | EUR 701 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-2-KE | |
| 2021-02-28 | Expenditure | EUR 2,039 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-3-KE | |
| 2021-02-28 | Expenditure | EUR 4,987 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-4-KE-CH-4 | |
| 2021-02-28 | Expenditure | EUR 194 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-1-MY | |
| 2021-02-28 | Expenditure | EUR 291 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-2-MY | |
| 2021-02-28 | Expenditure | EUR 822 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-1-TH | |
| 2021-02-28 | Expenditure | EUR 7,351 | Drugs for Neglected Diseases initiative | Expenses - 18-2102-1-US-CH-4 | |
| 2021-03-31 | Expenditure | EUR 48k | Drugs for Neglected Diseases initiative | Expenses - 18-2103-1-CH-FR-3 | |
| 2021-03-31 | Expenditure | EUR 6,210 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-2-CH | |
| 2021-03-31 | Expenditure | EUR 31k | Drugs for Neglected Diseases initiative | Expenses - 18-2103-3-CH | |
| 2021-03-31 | Expenditure | EUR 27k | Drugs for Neglected Diseases initiative | Expenses - 18-2103-4-CH | |
| 2021-03-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 18-2103-5-CH-CH-4 | |
| 2021-03-31 | Expenditure | EUR 2,934 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-1-FR-CH-4 | |
| 2021-03-31 | Expenditure | EUR 7,428 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-1-KE-FR-3 | |
| 2021-03-31 | Expenditure | EUR 825 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-2-KE | |
| 2021-03-31 | Expenditure | EUR 2,385 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-3-KE | |
| 2021-03-31 | Expenditure | EUR 3,987 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-4-KE-CH-4 | |
| 2021-03-31 | Expenditure | EUR 486 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-1-MY | |
| 2021-03-31 | Expenditure | EUR 584 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-2-MY | |
| 2021-03-31 | Expenditure | EUR 10 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-1-US | |
| 2021-03-31 | Expenditure | EUR 1,714 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-2-US | |
| 2021-03-31 | Expenditure | EUR 7,181 | Drugs for Neglected Diseases initiative | Expenses - 18-2103-3-US-CH-4 | |
| 2021-04-30 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 18-2104-1-CH-FR-3 | |
| 2021-04-30 | Expenditure | EUR 827 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-2-CH | |
| 2021-04-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 18-2104-3-CH | |
| 2021-04-30 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses - 18-2104-4-CH | |
| 2021-04-30 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 18-2104-5-CH-CH-4 | |
| 2021-04-30 | Expenditure | EUR 758 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-1-IN | |
| 2021-04-30 | Expenditure | EUR 8,145 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-1-KE-FR-3 | |
| 2021-04-30 | Expenditure | EUR 4,140 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-2-KE | |
| 2021-04-30 | Expenditure | EUR 1,914 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-3-KE | |
| 2021-04-30 | Expenditure | EUR 833 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-4-KE | |
| 2021-04-30 | Expenditure | EUR 1,790 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-5-KE-CH-4 | |
| 2021-04-30 | Expenditure | EUR 551 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-1-MY | |
| 2021-04-30 | Expenditure | EUR 584 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-2-MY | |
| 2021-04-30 | Expenditure | EUR 33k | Drugs for Neglected Diseases initiative | Expenses - 18-2104-1-SN-FR-3 | |
| 2021-04-30 | Expenditure | EUR 1,469 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-1-UG | |
| 2021-04-30 | Expenditure | EUR 2,427 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-1-US | |
| 2021-04-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 18-2104-2-US-FR-3 | |
| 2021-04-30 | Expenditure | EUR 4,077 | Drugs for Neglected Diseases initiative | Expenses - 18-2104-3-US-CH-4 | |
| 2021-05-31 | Expenditure | EUR 41k | Drugs for Neglected Diseases initiative | Expenses - 18-2105-1-CH-FR-3 | |
| 2021-05-31 | Expenditure | EUR 925 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-2-CH | |
| 2021-05-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 18-2105-3-CH | |
| 2021-05-31 | Expenditure | EUR 22k | Drugs for Neglected Diseases initiative | Expenses - 18-2105-4-CH | |
| 2021-05-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 18-2105-5-CH-CH-4 | |
| 2021-05-31 | Expenditure | EUR 4,550 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-1-ES-CH-4 | |
| 2021-05-31 | Expenditure | EUR 3,125 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-1-FR | |
| 2021-05-31 | Expenditure | EUR 1,482 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-1-IN | |
| 2021-05-31 | Expenditure | EUR 6,159 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-1-KE-FR-3 | |
| 2021-05-31 | Expenditure | EUR 1,534 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-2-KE | |
| 2021-05-31 | Expenditure | EUR 1,757 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-3-KE | |
| 2021-05-31 | Expenditure | EUR 3,492 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-4-KE-CH-4 | |
| 2021-05-31 | Expenditure | EUR 161 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-1-MY | |
| 2021-05-31 | Expenditure | EUR 483 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-2-MY | |
| 2021-05-31 | Expenditure | EUR 2,420 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-1-US | |
| 2021-05-31 | Expenditure | EUR 1,876 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-2-US | |
| 2021-05-31 | Expenditure | EUR 4,045 | Drugs for Neglected Diseases initiative | Expenses - 18-2105-3-US-CH-4 | |
| 2021-06-30 | Expenditure | EUR 28k | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-CH-FR-3 | |
| 2021-06-30 | Expenditure | EUR 2,657 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-2-CH | |
| 2021-06-30 | Expenditure | EUR 49k | Drugs for Neglected Diseases initiative | Expenses - 18-2106-3-CH | |
| 2021-06-30 | Expenditure | EUR 28k | Drugs for Neglected Diseases initiative | Expenses - 18-2106-4-CH | |
| 2021-06-30 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 18-2106-5-CH-CH-4 | |
| 2021-06-30 | Expenditure | EUR 3,171 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-DE | |
| 2021-06-30 | Expenditure | EUR 793 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-2-DE-CH-4 | |
| 2021-06-30 | Expenditure | EUR 651 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-IN | |
| 2021-06-30 | Expenditure | EUR 6,090 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-KE-FR-3 | |
| 2021-06-30 | Expenditure | EUR 1,517 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-2-KE | |
| 2021-06-30 | Expenditure | EUR 688 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-3-KE | |
| 2021-06-30 | Expenditure | EUR 4,725 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-4-KE-CH-4 | |
| 2021-06-30 | Expenditure | EUR 174 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-MY | |
| 2021-06-30 | Expenditure | EUR 6 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-2-MY | |
| 2021-06-30 | Expenditure | EUR 1,385 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-3-MY | |
| 2021-06-30 | Expenditure | EUR 2,047 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-TZ-CH-4 | |
| 2021-06-30 | Expenditure | EUR 3,557 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-US | |
| 2021-06-30 | Expenditure | EUR 6,249 | Drugs for Neglected Diseases initiative | Expenses - 18-2106-2-US-CH-4 | |
| 2021-06-30 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 18-2106-1-ZA | |
| 2021-07-31 | Expenditure | EUR 18k | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-CH-FR-3 | |
| 2021-07-31 | Expenditure | EUR 2,185 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-2-CH | |
| 2021-07-31 | Expenditure | EUR 41k | Drugs for Neglected Diseases initiative | Expenses - 18-2107-3-CH | |
| 2021-07-31 | Expenditure | EUR 8,604 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-4-CH-CH-4 | |
| 2021-07-31 | Expenditure | EUR 1,830 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-DE | |
| 2021-07-31 | Expenditure | EUR 3,548 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-2-DE-CH-4 | |
| 2021-07-31 | Expenditure | EUR 602 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-IN | |
| 2021-07-31 | Expenditure | EUR 6,119 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-KE-FR-3 | |
| 2021-07-31 | Expenditure | EUR 1,524 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-2-KE | |
| 2021-07-31 | Expenditure | EUR 1 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-3-KE | |
| 2021-07-31 | Expenditure | EUR 5,371 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-4-KE-CH-4 | |
| 2021-07-31 | Expenditure | EUR 1,680 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-MY | |
| 2021-07-31 | Expenditure | EUR 1,660 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-TH | |
| 2021-07-31 | Expenditure | EUR 880 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-TZ-CH-4 | |
| 2021-07-31 | Expenditure | EUR 4,211 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-UG | |
| 2021-07-31 | Expenditure | EUR 3,570 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-1-US | |
| 2021-07-31 | Expenditure | EUR 4,012 | Drugs for Neglected Diseases initiative | Expenses - 18-2107-2-US-CH-4 | |
| 2021-08-31 | Expenditure | EUR 68k | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-CH-FR-3 | |
| 2021-08-31 | Expenditure | EUR 497 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-2-CH | |
| 2021-08-31 | Expenditure | EUR 51 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-3-CH | |
| 2021-08-31 | Expenditure | EUR 3,250 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-4-CH | |
| 2021-08-31 | Expenditure | EUR 38k | Drugs for Neglected Diseases initiative | Expenses - 18-2108-5-CH | |
| 2021-08-31 | Expenditure | EUR 9,289 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-6-CH-CH-4 | |
| 2021-08-31 | Expenditure | EUR 1,233 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-DE | |
| 2021-08-31 | Expenditure | EUR 3,364 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-2-DE-CH-4 | |
| 2021-08-31 | Expenditure | EUR 4,751 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-FR | |
| 2021-08-31 | Expenditure | EUR 467 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-GB | |
| 2021-08-31 | Expenditure | EUR 644 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-IN | |
| 2021-08-31 | Expenditure | EUR 6,214 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-KE-FR-3 | |
| 2021-08-31 | Expenditure | EUR 1,547 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-2-KE | |
| 2021-08-31 | Expenditure | EUR 3,231 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-3-KE | |
| 2021-08-31 | Expenditure | EUR 602 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-4-KE-CH-4 | |
| 2021-08-31 | Expenditure | EUR 246 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-MY | |
| 2021-08-31 | Expenditure | EUR 8,820 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-SE | |
| 2021-08-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-TH | |
| 2021-08-31 | Expenditure | EUR 740 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-UG | |
| 2021-08-31 | Expenditure | EUR 572 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-2-UG-CH-4 | |
| 2021-08-31 | Expenditure | EUR 4,072 | Drugs for Neglected Diseases initiative | Expenses - 18-2108-1-US-CH-4 | |
| 2021-09-30 | Expenditure | EUR 8,523 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-BE | |
| 2021-09-30 | Expenditure | EUR 21k | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-CH-FR-3 | |
| 2021-09-30 | Expenditure | EUR 2,821 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-2-CH | |
| 2021-09-30 | Expenditure | EUR 37k | Drugs for Neglected Diseases initiative | Expenses - 18-2109-3-CH | |
| 2021-09-30 | Expenditure | EUR 8,754 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-4-CH-CH-4 | |
| 2021-09-30 | Expenditure | EUR 979 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-DE | |
| 2021-09-30 | Expenditure | EUR 2,733 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-2-DE-CH-4 | |
| 2021-09-30 | Expenditure | EUR 333 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-FR | |
| 2021-09-30 | Expenditure | EUR 3,185 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-GB | |
| 2021-09-30 | Expenditure | EUR 639 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-IN | |
| 2021-09-30 | Expenditure | EUR 6,779 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-KE-FR-3 | |
| 2021-09-30 | Expenditure | EUR 1,539 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-2-KE | |
| 2021-09-30 | Expenditure | EUR 176 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-MY | |
| 2021-09-30 | Expenditure | EUR 2,600 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-TH-FR-3 | |
| 2021-09-30 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 18-2109-2-TH-CH-4 | |
| 2021-09-30 | Expenditure | EUR 4,149 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-US-CH-4 | |
| 2021-09-30 | Expenditure | EUR 7,384 | Drugs for Neglected Diseases initiative | Expenses - 18-2109-1-ZA | |
| 2021-10-31 | Expenditure | EUR 50k | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-CH-FR-3 | |
| 2021-10-31 | Expenditure | EUR 195 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-2-CH | |
| 2021-10-31 | Expenditure | EUR 36k | Drugs for Neglected Diseases initiative | Expenses - 18-2110-3-CH | |
| 2021-10-31 | Expenditure | EUR 6,219 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-4-CH-CH-4 | |
| 2021-10-31 | Expenditure | EUR 662 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-DE | |
| 2021-10-31 | Expenditure | EUR 1,324 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-2-DE-CH-4 | |
| 2021-10-31 | Expenditure | EUR 423 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-GB | |
| 2021-10-31 | Expenditure | EUR 651 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-IN | |
| 2021-10-31 | Expenditure | EUR 6,132 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-KE-FR-3 | |
| 2021-10-31 | Expenditure | EUR 1,528 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-2-KE | |
| 2021-10-31 | Expenditure | EUR 284 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-MY | |
| 2021-10-31 | Expenditure | EUR 0 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-2-MY-CH-4 | |
| 2021-10-31 | Expenditure | EUR 6,888 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-TH-CH-4 | |
| 2021-10-31 | Expenditure | EUR 4,058 | Drugs for Neglected Diseases initiative | Expenses - 18-2110-1-US-CH-4 | |
| 2021-11-30 | Expenditure | EUR 71k | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-CH-FR-3 | |
| 2021-11-30 | Expenditure | EUR 33k | Drugs for Neglected Diseases initiative | Expenses - 18-2111-2-CH | |
| 2021-11-30 | Expenditure | EUR 5,765 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-3-CH-CH-4 | |
| 2021-11-30 | Expenditure | EUR 664 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-DE | |
| 2021-11-30 | Expenditure | EUR 1,107 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-2-DE-CH-4 | |
| 2021-11-30 | Expenditure | EUR 667 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-FR | |
| 2021-11-30 | Expenditure | EUR 314 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-IN | |
| 2021-11-30 | Expenditure | EUR 6,323 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-KE-FR-3 | |
| 2021-11-30 | Expenditure | EUR 1,553 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-2-KE | |
| 2021-11-30 | Expenditure | EUR 180 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-MY | |
| 2021-11-30 | Expenditure | EUR 1,039 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-UG | |
| 2021-11-30 | Expenditure | EUR 606 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-2-UG-CH-4 | |
| 2021-11-30 | Expenditure | EUR 4,162 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-1-US | |
| 2021-11-30 | Expenditure | EUR 6,449 | Drugs for Neglected Diseases initiative | Expenses - 18-2111-2-US-CH-4 | |
| 2021-12-31 | Expenditure | EUR 167k | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-CH-FR-3 | |
| 2021-12-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 18-2112-2-CH | |
| 2021-12-31 | Expenditure | EUR 23k | Drugs for Neglected Diseases initiative | Expenses - 18-2112-3-CH | |
| 2021-12-31 | Expenditure | EUR 71k | Drugs for Neglected Diseases initiative | Expenses - 18-2112-4-CH | |
| 2021-12-31 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 18-2112-5-CH-CH-4 | |
| 2021-12-31 | Expenditure | EUR 656 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-DE | |
| 2021-12-31 | Expenditure | EUR 1,313 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-2-DE-CH-4 | |
| 2021-12-31 | Expenditure | EUR 5,892 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-FR | |
| 2021-12-31 | Expenditure | EUR 866 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-IN | |
| 2021-12-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-KE-FR-3 | |
| 2021-12-31 | Expenditure | EUR 3,410 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-2-KE | |
| 2021-12-31 | Expenditure | EUR 889 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-3-KE | |
| 2021-12-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-TH | |
| 2021-12-31 | Expenditure | EUR 4,815 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-2-TH | |
| 2021-12-31 | Expenditure | EUR 9,502 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-US-CH-4 | |
| 2021-12-31 | Expenditure | EUR 4,249 | Drugs for Neglected Diseases initiative | Expenses - 18-2112-1-ZA | |
| 2023-01-31 | Expenditure | EUR 4,766 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-CD-FR-3 | |
| 2023-06-30 | Expenditure | EUR 1,017 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-2-GB | |
| 2023-06-30 | Expenditure | EUR 3,757 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-1-IN | |
| 2023-06-30 | Expenditure | EUR 1,298 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-1-KE | |
| 2023-06-30 | Expenditure | EUR 6,342 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-2-KE | |
| 2023-06-30 | Expenditure | EUR 150 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-3-KE | |
| 2023-06-30 | Expenditure | EUR 629 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-4-KE | |
| 2023-06-30 | Expenditure | EUR 8,958 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-5-KE | |
| 2023-06-30 | Expenditure | EUR 30 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-6-KE-CH-4 | |
| 2023-06-30 | Expenditure | EUR 383 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-1-MY | |
| 2023-06-30 | Expenditure | EUR 381 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-2-MY | |
| 2023-06-30 | Expenditure | EUR 614 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-3-MY-CH-4 | |
| 2023-06-30 | Expenditure | EUR 2,255 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-1-US | |
| 2023-06-30 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 18-2306-2-US | |
| 2023-06-30 | Expenditure | EUR 7 | Drugs for Neglected Diseases initiative | Expenses - 18-2306-3-US-CH-4 | |
| 2023-06-30 | Expenditure | EUR 20k | Drugs for Neglected Diseases initiative | Expenses - 18-2306-1-ZA | |
| 2023-07-31 | Expenditure | EUR 6,202 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-CD | |
| 2023-07-31 | Expenditure | EUR 141k | Drugs for Neglected Diseases initiative | Expenses - 18-2307-2-CD-FR-3 | |
| 2023-07-31 | Expenditure | EUR 213 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-3-CD | |
| 2023-07-31 | Expenditure | EUR 7,945 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-4-CD | |
| 2023-07-31 | Expenditure | EUR 4,779 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-CH | |
| 2023-07-31 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 18-2307-2-CH | |
| 2023-07-31 | Expenditure | EUR 38k | Drugs for Neglected Diseases initiative | Expenses - 18-2307-3-CH | |
| 2023-07-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 18-2307-4-CH-CH-4 | |
| 2023-07-31 | Expenditure | EUR 220 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-DE | |
| 2023-07-31 | Expenditure | EUR 1,649 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-GB | |
| 2023-07-31 | Expenditure | EUR 3,006 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-IN | |
| 2023-07-31 | Expenditure | EUR 377 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-2-IN-CH-4 | |
| 2023-07-31 | Expenditure | EUR 1,718 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-KE | |
| 2023-07-31 | Expenditure | EUR 1,138 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-2-KE | |
| 2023-07-31 | Expenditure | EUR 5,725 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-3-KE | |
| 2023-07-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 18-2307-4-KE | |
| 2023-07-31 | Expenditure | EUR 341 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-5-KE-CH-4 | |
| 2023-07-31 | Expenditure | EUR 298 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-MY | |
| 2023-07-31 | Expenditure | EUR 538 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-2-MY | |
| 2023-07-31 | Expenditure | EUR 244 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-3-MY-CH-4 | |
| 2023-07-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-SE | |
| 2023-07-31 | Expenditure | EUR 2,255 | Drugs for Neglected Diseases initiative | Expenses - 18-2307-1-US | |
| 2023-07-31 | Expenditure | EUR 10k | Drugs for Neglected Diseases initiative | Expenses - 18-2307-2-US | |
| 2023-08-31 | Expenditure | EUR 1,511 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-CD | |
| 2023-08-31 | Expenditure | EUR 45 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-2-CD-FR-3 | |
| 2023-08-31 | Expenditure | EUR 268 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-3-CD | |
| 2023-08-31 | Expenditure | EUR 5,203 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-4-CD | |
| 2023-01-31 | Expenditure | EUR -17k | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-CH | |
| 2023-01-31 | Expenditure | EUR 15k | Drugs for Neglected Diseases initiative | Expenses - 18-2301-2-CH-FR-3 | |
| 2023-01-31 | Expenditure | EUR -527 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-3-CH | |
| 2023-01-31 | Expenditure | EUR 24k | Drugs for Neglected Diseases initiative | Expenses - 18-2301-4-CH | |
| 2023-01-31 | Expenditure | EUR 17k | Drugs for Neglected Diseases initiative | Expenses - 18-2301-5-CH | |
| 2023-01-31 | Expenditure | EUR 2,193 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-6-CH-XM-DAC-7 | |
| 2023-01-31 | Expenditure | EUR 7,317 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-7-CH | |
| 2023-01-31 | Expenditure | EUR 12k | Drugs for Neglected Diseases initiative | Expenses - 18-2301-8-CH-CH-4 | |
| 2023-01-31 | Expenditure | EUR 800 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-DE-CH-4 | |
| 2023-01-31 | Expenditure | EUR 392 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-FR | |
| 2023-01-31 | Expenditure | EUR 817 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-GB-XM-DAC-7 | |
| 2023-01-31 | Expenditure | EUR -1,310 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-IN | |
| 2023-01-31 | Expenditure | EUR 2,076 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-2-IN | |
| 2023-01-31 | Expenditure | EUR -518 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-KE | |
| 2023-01-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 18-2301-2-KE-FR-3 | |
| 2023-01-31 | Expenditure | EUR 13k | Drugs for Neglected Diseases initiative | Expenses - 18-2301-3-KE | |
| 2023-01-31 | Expenditure | EUR 132 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-4-KE-XM-DAC-7 | |
| 2023-01-31 | Expenditure | EUR 35 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-5-KE | |
| 2023-01-31 | Expenditure | EUR 830 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-6-KE-CH-4 | |
| 2023-01-31 | Expenditure | EUR -153 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-1-MY | |
| 2023-01-31 | Expenditure | EUR 331 | Drugs for Neglected Diseases initiative | Expenses - 18-2301-2-MY | |
| 2023-08-31 | Expenditure | EUR 236 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-5-CD | |
| 2023-08-31 | Expenditure | EUR 2,677 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-6-CD-XM-DAC-30010 | |
| 2023-08-31 | Expenditure | EUR 3,453 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-CH | |
| 2023-08-31 | Expenditure | EUR 19k | Drugs for Neglected Diseases initiative | Expenses - 18-2308-2-CH | |
| 2023-08-31 | Expenditure | EUR 29k | Drugs for Neglected Diseases initiative | Expenses - 18-2308-3-CH | |
| 2023-08-31 | Expenditure | EUR 2,412 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-4-CH | |
| 2023-08-31 | Expenditure | EUR 14k | Drugs for Neglected Diseases initiative | Expenses - 18-2308-5-CH-CH-4 | |
| 2023-08-31 | Expenditure | EUR 9 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-6-CH-XM-DAC-30010 | |
| 2023-08-31 | Expenditure | EUR 2,935 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-GB | |
| 2023-08-31 | Expenditure | EUR 565 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-2-GB | |
| 2023-08-31 | Expenditure | EUR 2,499 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-IN | |
| 2023-08-31 | Expenditure | EUR 369 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-2-IN-CH-4 | |
| 2023-08-31 | Expenditure | EUR 1,339 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-KE | |
| 2023-08-31 | Expenditure | EUR 302 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-2-KE | |
| 2023-08-31 | Expenditure | EUR 5,623 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-3-KE | |
| 2023-08-31 | Expenditure | EUR 1,305 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-4-KE | |
| 2023-08-31 | Expenditure | EUR 7,576 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-5-KE | |
| 2023-08-31 | Expenditure | EUR 15 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-MY | |
| 2023-08-31 | Expenditure | EUR 524 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-2-MY | |
| 2023-08-31 | Expenditure | EUR 238 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-3-MY-CH-4 | |
| 2023-08-31 | Expenditure | EUR 350 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-SE | |
| 2023-08-31 | Expenditure | EUR 1,979 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-1-US | |
| 2023-08-31 | Expenditure | EUR 9,358 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-2-US | |
| 2023-08-31 | Expenditure | EUR 11 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-3-US | |
| 2023-08-31 | Expenditure | EUR 11 | Drugs for Neglected Diseases initiative | Expenses - 18-2308-4-US-CH-4 | |
| 2023-09-30 | Expenditure | EUR 3 | Drugs for Neglected Diseases initiative | Expenses - 18-2309-1-CD | |
| 2023-09-30 | Expenditure | EUR 1 | Drugs for Neglected Diseases initiative | Expenses - 18-2309-2-CD-FR-3 | |
| 2023-09-30 | Expenditure | EUR 1,375 | Drugs for Neglected Diseases initiative | Expenses - 18-2309-3-CD | |
| 2023-09-30 | Expenditure | EUR 6,868 | Drugs for Neglected Diseases initiative | Expenses - 18-2309-4-CD | |
| 2023-09-30 | Expenditure | EUR 4,067 | Drugs for Neglected Diseases initiative | Expenses - 18-2309-1-CH |
Showing 300 of 1,569. The API returns all of them.
Struck-through rows were in the previous version, last seen 2026-10-02 02:19 UTC, and are not in the current file.